Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

The S&P 500 Just Had One of Its Strangest Months in Years. History Says This Usually Doesn't Last.fool.com
The S&P 500 experienced a historic breadth divergence. It's possible that it doesn't end soon.
Via The Motley Fool · October 7, 2026
AI Stocks Micron and Sandisk Are Up 460% and 1,190% in the Past Year. History Says This Will Happen Next.fool.com
Micron and Sandisk shares could decline sharply as the memory chip supply shortage is resolved.
Via The Motley Fool · October 7, 2026
10-Year Treasuries Yield 5.3%; Schwab's Dividend ETF Yields 3.4%. Which One Should Income Investors Buy?fool.com
Locking in a high yield with Treasury bonds is becoming increasingly appealing.
Via The Motley Fool · October 7, 2026
Advanced Energy Industries (NASDAQ:AEIS): Affordable Growth With a Reasonable Forward Valuationchartmill.com
Via Chartmill · October 7, 2026
ASE Technology Holding (NYSE:ASX) Combines High Growth Momentum With a Breakout Setupchartmill.com
Via Chartmill · October 7, 2026
ATI INC (NYSE:ATI) Shows High Growth Momentum and a Breakout Setupchartmill.com
Via Chartmill · October 7, 2026
Expeditors Intl Wash Inc (NYSE:EXPD) Nears Breakout With Perfect Technical Strengthchartmill.com
Via Chartmill · October 7, 2026
Warren Buffett's Favorite Valuation Indicator Blew Past the Level He Warned Was "Playing With Fire." Here Are 3 Stocks Still Cheap Enough to Buy.fool.com
Buffett thinks many stocks are too hot to touch right now, but these three aren't.
Via The Motley Fool · October 7, 2026
ServiceTitan Unveils Max AI Platform to Build Self-Running Contractor Businessesmarketbeat.com
ServiceTitan (NASDAQ:TTAN) unveiled an AI-focused product strategy at its Pantheon 2026 event, introducing “Max,” which Chief Executive Officer and Co-Founder Ara Mahdessian described as a self-running, self-improving version of a contracting business. Mahdessian framed the company’s AI strategy as
Via MarketBeat · October 7, 2026
Meet the Dividend King That's Down 50% and Yields More Than It Has in Yearsfool.com
Hormel Foods stock is definitely out of favor, but it's a rebound candidate with a tasty dividend.
Via The Motley Fool · October 7, 2026
Social Security COLA Projections Are Slipping: What Retirees Need to Know Nowfool.com
Retirees should still receive a decent-sized benefits boost.
Via The Motley Fool · October 7, 2026
5 Stocks That Have Doubled Their Dividend in the Last 7 Years to Buy in Octoberfool.com
These five consumer stocks have all doubled their dividend payouts since 2019, and each has a fresh reason to believe the growth isn't finished.
Via The Motley Fool · October 7, 2026
History Says There Are $8.44 Trillion Reasons the Trump Bull Market Is Running on Borrowed Timefool.com
Money market fund investors are telling a chilling tale of what may come for a historically expensive stock market.
Via The Motley Fool · October 7, 2026
3 Magnificent Stocks Near 52-Week Lows to Buy in Octoberfool.com
These growing businesses are trading at reasonable valuations.
Via The Motley Fool · October 7, 2026
Is Micron a Buy After Its Latest Explosive Earnings Report? Here Are the Bull and Bear Cases.fool.com
Micron’s revenue soared in the triple digits in the quarter.
Via The Motley Fool · October 7, 2026
3 Top AI Stocks to Watch in October: They May Set the Tone for the Rest of the Market.fool.com
They may offer us important clues about what’s next for AI.
Via The Motley Fool · October 7, 2026
Marvell Now Sees as Much as $90 Billion in Annual Sales by Fiscal 2031. Here's Why It's a Chip Stock to Buy.fool.com
The top of the chipmaker's latest target is around 11 times its sales from last fiscal year. How much of this is already in the share price?
Via The Motley Fool · October 7, 2026
Sensei Biotherapeutics Highlights PIKTOR Strategy Ahead of Endometrial Trial Readoutmarketbeat.com
Faeth Therapeutics outlined its clinical strategy for PIKTOR, an oral combination designed to inhibit the PI3K/AKT/mTOR, or PAM, pathway at multiple points, during an analyst and investor event. The company is developing the regimen in endometrial cancer and hormone receptor-positive, HER2-negative
Via MarketBeat · October 7, 2026
1 Number That Might Explain Why Netflix (NFLX) Stock Is Down 27% in 2026fool.com
The streaming video leader is now in a more mature phase of its lifecycle.
Via The Motley Fool · October 7, 2026
The $500 Billion Question Causing Waves Across Every AI Stock: How Much Are Nvidia GPUs Actually Worth?fool.com
Nvidia and the big banks financing its growth disagree about the useful lifespan of its powerful processors.
Via The Motley Fool · October 7, 2026
Regulators Cleared a Small Modular Reactor for Construction. It Isn't a NuScale Design.fool.com
Being first to an approved design hasn't made the reactor developer first to a construction site.
Via The Motley Fool · October 7, 2026
Google Signs Nuclear Deal With Constellation Energyfool.com
The utility company will supply 3.59 gigawatts of power to the tech giant under long-term agreements.
Via The Motley Fool · October 7, 2026
Social Security’s 2027 COLA Announcement Is 1 Week Away. Here’s What All Retirees Should Knowfool.com
The big reveal doesn't have to come as a total shock.
Via The Motley Fool · October 7, 2026
Bill Ackman Called Howard Hughes Holdings a "Compounding Machine" He Wants to Turn Into a Trillion-Dollar Business Over the Next 50 Years. Here's Why the Market Might Be Underpricing That Bet.fool.com
Ackman is transforming Howard Hughes from a real estate business into an investment-led insurance business.
Via The Motley Fool · October 7, 2026
Contango ORE Highlights 140 g/t Gold Hit, Targets Lucky Shot Resource Growthmarketbeat.com
Contango ORE (NYSEAMERICAN:CTGO) discussed new drilling results and development plans for its Lucky Shot gold project in Alaska, highlighting high-grade intercepts from the completed Coleman surface drilling program and outlining a path toward an updated mineral resource estimate and feasibility stu
Via MarketBeat · October 7, 2026